The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Howe Jill Ann since 2024.
This trader's CIK number is 1892397.
At the time of last reporting, Howe Jill Ann was the Chief Financial Officer of Lineage Cell Therapeutics, Inc.. (stock ticker symbol LCTX).
Also see all insider trading activities at Lineage Cell Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | LCTX | 25,500 | $18,195 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-26 | LCTX | Buy | 15,000 | .59 | 8,850 |
| 2024-08-16 | LCTX | Buy | 10,500 | .89 | 9,345 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Howe Jill Ann (Chief Financial Officer of Lineage Cell Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.